A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury

NCT01748695 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Neuropathic Pain Due to Spinal Cord Injury

Interventions

DRUG: V158866
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]